NeuroMetrix is a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world. The Company has three FDA cleared commercial products. DPNCheck® is a point-of-care test that is used to evaluate peripheral neuropathies. ADVANCE® is a point-of-care device that provides nerve conduction studies as an aid in diagnosing and evaluating patients suspected of having focal or systemic neuropathies. Quell® Fibromyalgia is a wearable, mobile app enabled, neurostimulation device indicated to help reduce the symptoms of fibromyalgia in adults with high pain sensitivity. The Company maintains an active, industry-leading R&D program.
Events & Presentations
Feb 22, 2024 at 8:00 AM EST
Q4 and Year-End 2023 NeuroMetrix Inc. Earnings Conference CallTo participate in the live conference call via telephone, please register here.
Jan 10, 2024
Emerging Growth Conference